CorEvitas is a science-led, data intelligence company that provides real-world evidence through syndicated registry data and analytics, patient experience and insights, precision medicine solutions, as well as specialty EMR & claims data. CorEvitas powers the life sciences industry with the most objective clinical insights essential to bring safe and effective treatments to market. CorEvitas' data are considered the gold standard in observational research and have been used in over 140 peer reviewed manuscripts and 430 abstracts. CorEvitas has conducted active safety surveillance to support regulatory commitments for 14 new drug approvals, including formal post authorization safety studies.